A Novel Case of Ischemic Colitis in the Setting of Kratom Use: A Case Report.

IF 0.7 Q4 GASTROENTEROLOGY & HEPATOLOGY
Case Reports in Gastroenterology Pub Date : 2025-08-20 eCollection Date: 2025-01-01 DOI:10.1159/000546558
Landen Shane Burstiner, Yasasvhinie Santharam, Christopher Mikulas, Avni Agrawal, Reshmi Mathew, Peter Senada, Maged Peter Ghali
{"title":"A Novel Case of Ischemic Colitis in the Setting of Kratom Use: A Case Report.","authors":"Landen Shane Burstiner, Yasasvhinie Santharam, Christopher Mikulas, Avni Agrawal, Reshmi Mathew, Peter Senada, Maged Peter Ghali","doi":"10.1159/000546558","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Kratom is an herbal preparation - generally an extract, capsule, chew, or smoking substrate - made from the leaves of a tropical tree (<i>Mitragyna speciosa</i>) that is indigenous to Southeast Asia. Its physiological effects are complex and dose dependent: low doses mimic stimulants, while higher doses have sedative and analgesic effects. Although injury and failure of various organs have been reported with kratom use across multiple case study analyses, gastrointestinal involvement has been rarely documented.</p><p><strong>Case presentation: </strong>We present a 26-year-old female with no past medical history, no risk factors for intestinal ischemia, and an addiction to the commercial substance, kratom, who presented for 1 day of bright-red bloody diarrhea and bilious vomiting, and several weeks of intermittent sharp abdominal pain. Colonoscopy showed decreased mucosa vascular pattern in watershed areas of the colon and a splenic flexure that was so ulcerated it could not be safely traversed.</p><p><strong>Conclusion: </strong>Given the lack of concomitant risk factors and comorbidities, as well as the timing of her symptoms beginning well before she started any medications, our most likely patient developed ischemic colitis due to her kratom use. This is further supported by her repeat colonoscopy 2 months after quitting kratom, which showed complete resolution. We would advise vigilance for possible bowel ischemia in those using kratom, a substance on which there is currently limited knowledge.</p>","PeriodicalId":9614,"journal":{"name":"Case Reports in Gastroenterology","volume":"19 1","pages":"590-595"},"PeriodicalIF":0.7000,"publicationDate":"2025-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12503479/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports in Gastroenterology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000546558","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Kratom is an herbal preparation - generally an extract, capsule, chew, or smoking substrate - made from the leaves of a tropical tree (Mitragyna speciosa) that is indigenous to Southeast Asia. Its physiological effects are complex and dose dependent: low doses mimic stimulants, while higher doses have sedative and analgesic effects. Although injury and failure of various organs have been reported with kratom use across multiple case study analyses, gastrointestinal involvement has been rarely documented.

Case presentation: We present a 26-year-old female with no past medical history, no risk factors for intestinal ischemia, and an addiction to the commercial substance, kratom, who presented for 1 day of bright-red bloody diarrhea and bilious vomiting, and several weeks of intermittent sharp abdominal pain. Colonoscopy showed decreased mucosa vascular pattern in watershed areas of the colon and a splenic flexure that was so ulcerated it could not be safely traversed.

Conclusion: Given the lack of concomitant risk factors and comorbidities, as well as the timing of her symptoms beginning well before she started any medications, our most likely patient developed ischemic colitis due to her kratom use. This is further supported by her repeat colonoscopy 2 months after quitting kratom, which showed complete resolution. We would advise vigilance for possible bowel ischemia in those using kratom, a substance on which there is currently limited knowledge.

Abstract Image

Abstract Image

Abstract Image

克拉通用药环境下缺血性结肠炎1例报告。
Kratom是一种草药制剂-通常是提取物,胶囊,咀嚼或吸烟基质-由东南亚土著热带树木(Mitragyna speciosa)的叶子制成。其生理作用复杂且剂量依赖:低剂量类似兴奋剂,而高剂量具有镇静和镇痛作用。虽然在多个案例研究分析中已经报道了使用kratom会造成各种器官的损伤和衰竭,但很少有涉及胃肠道的记录。病例介绍:我们报告一名26岁的女性,无既往病史,无肠缺血危险因素,并对商业物质kratom成瘾,她表现为1天鲜红色血性腹泻和胆汁性呕吐,以及数周的间歇性剧烈腹痛。结肠镜检查显示结肠分水岭区粘膜血管模式减少,脾脏屈曲溃烂,无法安全通过。结论:考虑到缺乏伴随的危险因素和合并症,以及她的症状在她开始任何药物之前就开始了,我们的患者很可能是由于她使用了克拉通而患上了缺血性结肠炎。停药2个月后再次结肠镜检查进一步证实了这一点,结肠镜检查显示完全消退。我们建议对使用kratom的人警惕可能的肠缺血,目前对这种物质的了解有限。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Case Reports in Gastroenterology
Case Reports in Gastroenterology Medicine-Gastroenterology
CiteScore
1.10
自引率
0.00%
发文量
99
审稿时长
7 weeks
期刊介绍:
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书